Rising Demand for Plasma Thromboplastin Antecedent Market Key Players, Growth Analysis during 2021-2027
The global plasma thromboplastin antecedent market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Plasma thromboplastin antecedent is a clotting factor whose absence is associated with a form of hemophilia coagulation factor (whose deficiency results in a hemorrhagic tendency). The major factor attributable to the market growth includes the rising prevalence of CVD, thrombosis, infectious disease, and other diseases globally. Among these, the growing global population suffering from CVD illnesses is the primary factor for the increased market growth. Globally, almost 15 million people suffer from heart attacks or similar issues, according to the World Heart Federation. In the US, one person dies from cardiovascular disease every 36 seconds.
To Request a Sample of our Report on Plasma
Thromboplastin Antecedent Market: https://www.omrglobal.com/request-sample/plasma-thromboplastin-antecedent-market
Heart disease claims the lives of around 659,000 people in
the US each year, accounting for one out of every four mortalities. Between
2016 and 2017, the US spent $363 billion on heart disease. This covers the cost
of healthcare services, medications, and lost productivity as a result of
mortality. The most frequent type of heart illness, coronary heart disease
killed 360,900 people in 2019. These diseases affect approximately 18.2 million
persons aged 20 and up (about 6.7%). Adults under the age of 65 account for
about 2 out of every 10 mortalities due to coronary artery disease. Thus, the
growing application of plasma thromboplastin antecedent in such diseases is
likely to spur the market growth.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
Bayer AG, and Bristol-Myers Squibb Co., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Plasma Thromboplastin Antecedent Market is Available @ https://www.omrglobal.com/industry-reports/plasma-thromboplastin-antecedent-market
Global Plasma Thromboplastin Antecedent Market Report by
Segment
By Type
•
BAY-1213790
•
BMS-262084
•
EP-7041
•
IONIS-FXILRx
•
Others
By Application
•
CVD
•
Infectious Disease
•
Thrombosis
•
Others
Global Plasma Thromboplastin Antecedent Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment